Total Clarity Wealth Management’s Pfizer PFE Stock Holding History

Total Clarity Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Sell	12,728 -22,589	-64%	-$591K	0.06%	300
2026 Q1	$992K	Sell	35,317 -192	-0.5%	-$5.11K	0.23%	107
2025 Q4	$884K	Buy	35,509 +1,048	+3%	+$26.4K	0.21%	119
2025 Q3	$878K	Buy	+34,461	New	+$851K	0.23%	113
2023 Q1	–	Sell	-17,747	Closed	-$909K	–	230
2022 Q4	$909K	Sell	17,747 -291	-2%	-$14K	0.46%	55
2022 Q3	$789K	Buy	18,038 +1,212	+7%	+$58.9K	0.49%	56
2022 Q2	$882K	Buy	16,826 +1,252	+8%	+$63.8K	0.46%	54
2022 Q1	$806K	Sell	15,574 -1,968	-11%	-$102K	0.44%	62
2021 Q4	$1.04M	Buy	17,542 +802	+5%	+$39.7K	0.47%	55
2021 Q3	$720K	Sell	16,740 -73	-0.4%	-$3.23K	0.34%	76
2021 Q2	$658K	Buy	16,813 +602	+4%	+$23.4K	0.37%	84
2021 Q1	$587K	Sell	16,211 -1,297	-7%	-$46.1K	0.34%	74
2020 Q4	$644K	Sell	17,508 -664	-4%	-$24.4K	0.45%	60
2020 Q3	$633K	Buy	18,172 +761	+4%	+$26.7K	0.55%	51
2020 Q2	$540K	Sell	17,411 -209	-1%	-$7.1K	0.5%	57
2020 Q1	$546K	Sell	17,620 -1,024	-5%	-$34.9K	0.84%	35
2019 Q4	$693K	Buy	+18,644	New	+$664K	0.52%	46

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Total Clarity Wealth Management's PFE Position: Q2 2026 in Review

Total Clarity Wealth Management reduced its Pfizer (PFE) stake by 64% in Q2 2026, selling an estimated $591K and leaving 12,728 shares worth $306K. The position accounts for 0.06% of the portfolio, ranked #300.

Total Clarity Wealth Management first reported a position in PFE in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.04M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Total Clarity Wealth Management held 12,728 shares of Pfizer worth $306K as of Q2 2026.
Total Clarity Wealth Management sold 22,589 Pfizer shares in Q2 2026, an estimated $591K.
Pfizer made up 0.06% of Total Clarity Wealth Management's portfolio in Q2 2026, its #300 holding.
Total Clarity Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 17 quarters since.
Total Clarity Wealth Management's Pfizer position peaked at $1.04M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.